Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study
Terauchi, Yasuo, Satoi, Yoichi, Takeuchi, Masakazu, Imaoka, TakeshiVolume:
61
Year:
2014
Language:
english
Journal:
Endocrine Journal
DOI:
10.1507/endocrj.ej14-0147
File:
PDF, 1.33 MB
english, 2014